Hotline - Valvular and structural interventions

Anchorperson: S. Kapadia

Spokesperson: P. Freeman

Summary

This session presents pivotal advances in valvular and structural heart interventions, covering the SMART-MV trial on mitral valvotomy safety, outcomes of TAVR patients with tricuspid regurgitation undergoing TEER, and the application of the FLOWer embolic protection system across structural heart procedures. Additionally, it explores the impact of device implantation depth on blood flow dynamics post-LAA occlusion and addresses frailty considerations in patients undergoing percutaneous LAA closure through insights from the Frail-LAAC study.

Presentations available when logged in:

SMART-MV: Safety of Mitral vAlvotomy Randomised trial and OTW vs. standard
Outcomes of TAVR-patients with tricuspid regurgitation undergoing TEER
Use of the FLOWer embolic protection system across structural heart interventions
Impact of device implantation depth on blood flow dynamics after LAA occlusion
Frailty in patients undergoing percutaneous LAA closure: the Frail-LAAC study

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Hotline - Valvular and structural interventions

Log in or create account for free